ABBV
AbbVie Inc. · $250.94 (-2.5%) · mkt cap $443.4B · P/E 70.9
36 hub catalysts across 9 sources · backtest → · ← Ticker Explorer
Analyst Ratings (Upgrades/Downgrades)Earnings (SEC EDGAR)U.S. House — Congressional TradesInsider Transactions (SEC Form 4)Financial News (Google News)FDA Approvals & RecallsSEC EDGAR FilingsU.S. Senate — Congressional TradesWikipedia Pageviews (Attention)
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
100▼ Bear-leanconviction from hub signals
Bullish factors
- Congress bought (1)
- 1 analyst upgrade
Bearish factors
- Congress sold (1)
- FDA recall
- 1 analyst downgrade
- Insiders net selling (12 vs 0)
Context (not directional): News flow (4 recent) · Wikipedia attention spike
Signal mix for ABBV
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeStochastic Oscillator has fit ABBV best over 2 years (+101.7%, Sharpe 1.45). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Stochastic Oscillator | +101.7% | 1.45 | ✓ |
| 2 | Williams %R | +101.7% | 1.45 | ✓ |
| 3 | Z-Score Mean-Reversion | +48.2% | 0.96 | ✓ |
Price — 1 year
daily closeInsider activity
0 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-03-04 | SELL | Purdue David Ryan | 5,230 | $1.2M |
| 2026-03-02 | SELL | Siatis Perry C. | 18,668 | $4.4M |
| 2026-02-25 | SELL | Siatis Perry C. | 22,381 | $5.1M |
| 2025-08-12 | SELL | Saleki-Gerhardt Azita | 42,370 | $8.4M |
| 2025-08-05 | SELL | Donoghoe Nicholas | 13,295 | $2.6M |
| 2025-03-31 | SELL | Stewart Jeffrey Ryan | 58,832 | $12.4M |
| 2025-03-14 | SELL | Reents Scott T. | 17,644 | $3.7M |
| 2025-03-03 | SELL | Siatis Perry C. | 27,900 | $5.8M |
| 2025-03-03 | SELL | Gonzalez Richard A | 98,628 | $20.3M |
| 2025-03-03 | SELL | Richmond Timothy J | 21,250 | $4.5M |
| 2025-02-26 | SELL | Buckbee Kevin K | 18,944 | $3.9M |
| 2025-02-26 | SELL | Richmond Timothy J | 29,917 | $6.1M |
Analyst ratings
live · 5 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-04-21 | Initiated | Canaccord Genuity | Buy |
| 2026-02-25 | Initiated | RBC Capital | Outperform |
| 2026-02-20 | Initiated | Barclays | Overweight |
| 2026-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-12-10 | Upgrade | HSBC | Hold → Buy |
Catalyst timeline
36 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-08-01 | Earnings (SEC EDGAR) | Earnings (est.) | ABBV next report ~2026-08-05 (estimated) | ||
| 2026-08-01 | Financial News (Google News) | News | AbbVie (ABBV) Stock Could Sit Below Fair Value While Earnings Look Rich - simplywall.st | 21 | source ↗ |
| 2026-07-31 | Earnings (SEC EDGAR) | Earnings 8-K | ABBV earnings announcement (8-K item 2.02) | source ↗ | |
| 2026-07-31 | SEC EDGAR Filings | 8-K Event | AbbVie Inc. | source ↗ | |
| 2026-07-06 | Earnings (SEC EDGAR) | Earnings 8-K | ABBV earnings announcement (8-K item 2.02) | source ↗ | |
| 2026-07-06 | SEC EDGAR Filings | 8-K Event | AbbVie Inc. | source ↗ | |
| 2026-06-25 | Wikipedia Pageviews (Attention) | Wiki Attention | AbbVie: 666 views/day (1.37x normal) | 1.4× attention | source ↗ |
| 2026-06-24 | Financial News (Google News) | News | AbbVie (ABBV) Stock Draws Fresh Price Target Split After Apogee Deal - Yahoo Finance | 12 | source ↗ |
| 2026-06-24 | Financial News (Google News) | News | AbbVie (ABBV) Stock Draws Fresh Price Target Split After Apogee Deal - Yahoo Finance | 11 | source ↗ |
| 2026-06-23 | Wikipedia Pageviews (Attention) | Wiki Attention | AbbVie: 839 views/day (1.72x normal) | 1.7× attention | source ↗ |
| 2026-06-23 | Financial News (Google News) | News | AbbVie Inc. (ABBV) Apogee Therapeutics, Inc. - M&A Call - Slideshow (NYSE:ABBV) 2026-06-23 - Seeking Alpha | 20 | source ↗ |
| 2026-06-22 | SEC EDGAR Filings | 8-K Event | AbbVie Inc. | source ↗ | |
| 2026-06-03 | FDA Approvals & Recalls | FDA Recall | Class III: PRED MILD, prednisolone acetate ophthalmic suspension, — AbbVie Inc. | Class III | source ↗ |
| 2026-05-05 | U.S. House — Congressional Trades | Congress SELL | Hon. Josh Gottheimer | $1,001 - $15,000 | source ↗ |
| 2026-04-29 | Earnings (SEC EDGAR) | Earnings 8-K | ABBV earnings announcement (8-K item 2.02) | source ↗ | |
| 2026-04-21 | Analyst Ratings (Upgrades/Downgrades) | Analyst Initiated | Canaccord Genuity: Initiated (Buy) | source ↗ | |
| 2026-04-03 | Earnings (SEC EDGAR) | Earnings 8-K | ABBV earnings announcement (8-K item 2.02) | source ↗ | |
| 2026-03-27 | U.S. Senate — Congressional Trades | Congress BUY | Armstrong, Alan (Senator) | $15,001 - $50,000 | source ↗ |
| 2026-03-04 | Insider Transactions (SEC Form 4) | Insider SELL | Purdue David R. sold 5,230 sh | $1.2M | source ↗ |
| 2026-03-04 | Insider Transactions (SEC Form 4) | Insider SELL | Purdue David Ryan sold 5,230 sh | $1.2M | source ↗ |
| 2026-03-02 | Insider Transactions (SEC Form 4) | Insider SELL | Siatis Perry C. sold 18,668 sh | $4.4M | source ↗ |
| 2026-02-25 | Insider Transactions (SEC Form 4) | Insider SELL | Siatis Perry C. sold 22,381 sh | $5.1M | source ↗ |
| 2026-02-25 | Analyst Ratings (Upgrades/Downgrades) | Analyst Initiated | RBC Capital: Initiated (Outperform) | source ↗ | |
| 2026-02-20 | Analyst Ratings (Upgrades/Downgrades) | Analyst Initiated | Barclays: Initiated (Overweight) | source ↗ | |
| 2026-01-08 | Analyst Ratings (Upgrades/Downgrades) | Analyst Downgrade | Wolfe Research: Downgrade (Outperform → Peer Perform) | source ↗ | |
| 2025-08-12 | Insider Transactions (SEC Form 4) | Insider SELL | Saleki-Gerhardt Azita sold 42,370 sh | $8.4M | source ↗ |
| 2025-08-05 | Insider Transactions (SEC Form 4) | Insider SELL | Donoghoe Nicholas sold 13,295 sh | $2.6M | source ↗ |
| 2025-03-31 | Insider Transactions (SEC Form 4) | Insider SELL | Stewart Jeffrey Ryan sold 58,832 sh | $12.4M | source ↗ |
| 2025-03-14 | Insider Transactions (SEC Form 4) | Insider SELL | Reents Scott T. sold 17,644 sh | $3.7M | source ↗ |
| 2025-03-03 | Insider Transactions (SEC Form 4) | Insider SELL | Richmond Timothy J sold 21,250 sh | $4.5M | source ↗ |
| 2025-03-03 | Insider Transactions (SEC Form 4) | Insider SELL | Gonzalez Richard A sold 98,628 sh | $20.3M | source ↗ |
| 2025-03-03 | Insider Transactions (SEC Form 4) | Insider SELL | Siatis Perry C. sold 27,900 sh | $5.8M | source ↗ |
| 2018-11-07 | Earnings (SEC EDGAR) | Earnings | ABBV FY2018Q3 results | 8.2B | source ↗ |
| 2018-11-07 | Earnings (SEC EDGAR) | Earnings | ABBV FY2018Q3 results | 7.0B | source ↗ |
| 2018-08-07 | Earnings (SEC EDGAR) | Earnings | ABBV FY2018Q2 results | 8.3B | source ↗ |
| 2018-05-04 | Earnings (SEC EDGAR) | Earnings | ABBV FY2018Q1 results | 7.9B | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-08-01 10:45 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice